Prescription Benefits

CMS Final Rule for Drug Prices in Advertising

[vc_row][vc_column][rev_slider_vc alias="cms-final-drug-rule"][/vc_column][/vc_row][vc_row][vc_column width="1/2"][vc_column_text]A rule proposed in October of last year has become final on May 8, 2019. This rule would mandate that pharmaceutical companies publish the prices of any medication with a list price greater than $35 during television ads. Pharmaceutical companies tried to push back on this rule stating that listing the prices would confuse patients since what they pay will be different due to insurance coverage, rebates, and discounts....

Donna White
Share
2018 year in review

2018: A Year in Review

[vc_row][vc_column][rev_slider_vc alias="2018-in-review"][/vc_column][/vc_row][vc_row][vc_column width="1/2"][vc_column_text]We’re not exactly sure how, but 2018 has truly seemed to be an incredibly long year. That could be because of so many top news items in healthcare over the year. We thought we’d take this time as the year winds down to highlight some of the top items from our blog over the last year. Early in the year we discussed your charge master and how critical it...

Donna White
Share
CMS Final Rule 2019

CMS Final Rule 2019

[vc_row][vc_column][rev_slider_vc alias="cms-2019-final-rule"][/vc_column][/vc_row][vc_row][vc_column width="1/2"][vc_column_text]November sees the publishing of Medicare’s final rules for 2019. It has allowed for sweeping changes to Telehealth, provider reimbursement and Quality reporting. Medicare will now reimburse for patients connecting with their provider in a telecommute session to determine if an in-office visit is necessary. Changes made to the Quality Payment Program (QPP) will shift the focus from paperwork to positively impacting health outcomes. The key focus is on sharing...

Donna White
Share